ucsf logo

M. Anthony Pogrel, MD, MB CHB, BDS

Oral and Maxillofacial Surgery
Portrait of M. Anthony Pogrel
Portrait of M. Anthony Pogrel
ucsf logo

M. Anthony Pogrel, MD, MB CHB, BDS

Oral and Maxillofacial Surgery

On this page

About me

Dr. M. Anthony Pogrel is an oral and maxillofacial (jaw and face) surgeon. He specializes in head and neck conditions, temporomandibular joint surgery, orthognathic surgery (jaw correction) and surgical use of lasers.

Pogrel conducts research on new treatments for oral and maxillofacial conditions, including salivary gland tumors and problems with facial nerves.

Pogrel earned his doctor of dental surgery degree at the University of Liverpool in England and his medical degree at the University of Aberdeen in Scotland. He completed general surgery training in Great Britain, followed by oral and maxillofacial surgery training in Great Britain, the Netherlands and the United States.

Pogrel joined UCSF in 1983. He is a fellow of the Royal College of Surgeons of Edinburgh and American College of Surgeons.

Education & training

Board certification

  • Oral and Maxillofacial Surgery, American Board of Oral & Maxillofacial Surgery

Residency

  • General Surgery, UCSF Medical Center - OMAG
  • Oral & Maxillofacial Surgery, North Wales Hospital
  • Oral & Maxillofacial Surgery, Pioneer Community Hospital of Aberdeen
  • Dentistry, Liverpool University

Internship

  • General Surgery, Aberdeen Royal Infirmary
  • Dentistry, Liverpool University

Degree

  • MBBS, University of Aberdeen School of Medicine

My expertise

My research

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.